Luliconazole Formulation Stability and Transdermal Absorbability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antifungal agents for external use face challenges in maintaining the steric structure of novel imidazole compounds, such as luliconazole, which affects their stability and transdermal absorbability, particularly for conditions like seborrheic dermatitis, where solubility and irritation concerns are prevalent.
Innovation Solution
A formulation comprising 50-95% alcohol, 0.1-35% water, and 0.01-5% cellulose-based thickener, specifically incorporating ethanol and hydroxypropylcellulose, is developed to maintain the steric structure and enhance transdermal absorbability of luliconazole, forming a single-phase solution that avoids flammable solvents and minimizes irritation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a compound with asymmetric carbon (luliconazole) is formulated for external use, then antifungal activity is achieved, but the steric structure becomes unstable in solution
Solution Approach 1:
The patent changes the physical and chemical parameters of the formulation by controlling pH within a specific range (4.0-6.5) and selecting appropriate alcohol types and concentrations. These parameter changes create an environment that stabilizes the steric structure of luliconazole while maintaining its antifungal activity and solubility.
Solution Approach 2:
The patent uses a composite formulation system combining multiple components: alcohol (50-95 mass%), water (0.1-35 mass%), and cellulose-based thickener (0.01-5 mass%). This composite material approach creates synergistic effects that stabilize the asymmetric carbon structure while ensuring proper drug delivery and skin penetration.
2Ease of operation
If the concentration of alcohol is increased to improve solubility, then transdermal absorbability is enhanced, but irritation to the skin increases
Solution Approach 1:
The patent optimizes the alcohol concentration parameter within a specific range (50-95 mass%) and combines it with water and cellulose-based thickener. This parameter optimization ensures sufficient solubility and transdermal penetration while the presence of water and thickener mitigates the irritating effects of high alcohol concentrations.
Solution Approach 2:
The patent introduces water and cellulose-based thickener as intermediary substances that mediate between the alcohol and the skin. These intermediaries reduce the direct contact and potential damage of high-concentration alcohol to the skin while maintaining the solubility and penetration-enhancing properties.
3Ease of operation
If flammable solvents are used to achieve single-phase solution, then transdermal delivery is improved, but safety concerns and irritation risks increase
Solution Approach 1:
The patent replaces dangerous flammable solvents with safer alternatives (alcohol, water, cellulose-based thickener) that provide equivalent or superior performance. The alcohol-based formulation achieves single-phase solution and good transdermal delivery without the severe flammability and irritation risks of traditional flammable solvents.
4Reliability
If oral administration is used to deliver antifungal drugs, then therapeutic effect is achieved, but burden on liver and kidneys increases due to first-pass metabolism
Solution Approach 1:
The patent extracts the antifungal agent from systemic circulation and delivers it directly to the target site (skin) through topical application. This eliminates the first-pass metabolism in the liver and reduces the burden on kidneys by avoiding systemic distribution and renal excretion, while maintaining therapeutic effectiveness at the application site.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation provides a stable and highly absorbable antifungal agent suitable for treating mycoses like seborrheic dermatitis, improving the compound's stability and skin penetration without causing irritation, thus addressing the limitations of existing formulations.
Implementation Method 1
the compound represented by the general formula (1) is dissolved by polyethylene glycol, to thereby provide satisfactory stability
Implementation Method 2
a formulation in which the steric structure of a compound represented by the general formula (1) is maintained in a stable state, and the transdermal absorbability is improved
Implementation Method 3
because the steric structure of a compound having an asymmetric carbon is unstable in a solution, the maintenance of the steric structure becomes a critical issue
Data Source
AI summary
Disclosed is an antifungal agent for external use, which is characterized by containing a compound represented by the general formula (1), 50 to 95 mass % of an alcohol such as ethanol, 0.1 to 35 mass % of water or the like, and 0.01 to 5 mass % of a cellulose thickening agent. X is a halogen or H.